HOYA Corporation

¥27545 JPY 9.3T market cap 2026-02-23

HOYA CORP 7741 BUFFETT / MUNGER / KLARMAN SUMMARY

1 SNAPSHOT

Price¥27545

Market CapJPY 9.3T

EVJPY 8.8T

Net DebtJPY -539.2B (net cash)

Shares338.1M

2 BUSINESS

HOYA is a global med-tech and optical technology conglomerate operating in two segments: Life Care (67% of revenue -- eyeglass lenses, contact lenses, medical endoscopes, intraocular lenses) and Information Technology (33% of revenue but ~50% of profit -- EUV mask blanks for semiconductors, HDD glass substrates). The company commands monopoly-like positions in EUV mask blanks (75%+ share) and HDD glass substrates (100% share).

Revenue: JPY 885.8B Organic Growth: 9.7%

3 MOAT WIDE

1. EUV mask blank near-monopoly (75%+ share) with 5-7 year requalification cycles, $2.5-3.0B greenfield replication cost, and co-development lock-in with ASML. Only vendor validated for High-NA EUV (sub-2nm nodes). 2. HDD glass substrate absolute monopoly (100% share). 3. #2 global eyeglass lens maker (~20% share) with aging demographic tailwinds. 4. Capital-light business model with capex consistently below depreciation.

4 MANAGEMENT

CEO: Eiichiro Ikeda (since 2022)

Shareholder-oriented. Returns ~JPY 100-138B annually via buybacks and dividends (74% of FCF). Systematically exits obsolete businesses and reallocates capital to higher-return niches. Share count reduction has boosted EPS growth ~1% above net income growth annually. Maintains fortress balance sheet with JPY 539B net cash. Payout ratio on FCF only ~20%, leaving ample capacity for opportunistic buybacks and M&A.

5 ECONOMICS

42.7% Op Margin

33.3% ROIC

JPY 187.2B FCF

-2.2x (net cash) Debt/EBITDA

6 VALUATION

FCF/ShareJPY 554

FCF Yield2.0%

DCF RangeJPY 14,400 - 25,300

Three-scenario DCF using 8-12% FCF growth for years 1-5, transitioning to 5.5-8% for years 6-10, with 3-4% terminal growth rates and 8-9% discount rates. Starting FCF/share of JPY 554 plus JPY 1,595 net cash per share. Even optimistic scenario (JPY 25,275) falls short of current price.

7 MUNGER INVERSION -32.5%

Kill Event	Severity	P()	E[Loss]
Valuation compression from 45x to 30x P/E	-33%	40%	-13.2%
Semiconductor cyclical downturn	-20%	35%	-7.0%
Yen appreciation (150 to 120 vs USD)	-15%	30%	-4.5%
EUV competitive entry or technology shift	-40%	10%	-4.0%
Life Care competitive pressure and margin erosion	-15%	25%	-3.75%

Tail Risk: A simultaneous semiconductor downturn, yen strengthening, and multiple compression could trigger a 40-50% drawdown to JPY 14,000-16,500 -- a scenario that essentially occurred in mid-2024 when the stock bottomed at JPY 14,441. The probability of such convergence in any given year is approximately 10-15%.

8 KLARMAN LENS

Downside Case

In a bear scenario: semiconductor downturn reduces IT segment profits 25%, yen strengthens to 120/USD cutting translated earnings 15%, and the market re-rates the stock to 25x P/E. This implies a price of ~JPY 12,000-14,000, a 50%+ decline. The fortress balance sheet (JPY 539B net cash) limits permanent capital loss, but patient investors should demand a wider margin of safety at entry.

Why Market Wrong

The market may underappreciate the structural growth in EUV mask blanks as advanced nodes (3nm, 2nm, below) require exponentially more EUV layers per wafer. High-NA EUV -- where HOYA is the sole qualified supplier -- could create a step-change in mask blank demand and pricing power. The life care business provides stable earnings ballast that the market may be undervaluing at a semiconductor-cycle premium multiple.

Why Market Right

The stock's premium valuation reflects genuine quality. HOYA has compounded ROE above 20% for two decades with near-zero leverage. The EUV thesis is well-known among institutional investors. AGC is investing to close the technology gap. HDD glass substrates face secular decline. At 45x earnings, the market may be exactly right -- pricing a wonderful business fairly.

Catalysts

1. Semiconductor downturn creating cyclical entry point (2026-2027). 2. Yen normalization from extreme weakness. 3. High-NA EUV volume ramp confirmation (2026-2027). 4. Potential index reconstitution events or governance reforms.

9 VERDICT WAIT

A T1 Fortress

Strong Buy¥14400

Buy¥18600

Sell¥27800

HOYA is an A+ quality business trading at a price that demands perfection. With 45x trailing earnings, 2% FCF yield, and even optimistic DCF scenarios falling short of the current price, the margin of safety is nonexistent. Patient investors should wait for a semiconductor downturn, yen reversal, or market correction to bring the stock below JPY 19,000 before building a position. The stock hit JPY 14,441 just ten months ago -- patience pays.

🧠 ULTRATHINK Deep Philosophical Analysis

HOYA Corporation (7741) -- Deep Philosophical Analysis

Buffett-Munger style meditation on business quality, price, and patience

1. The Real Question

The real question with HOYA is not whether this is a great business. It obviously is. The real question is whether a great business at a rich price can still be a great investment.

Warren Buffett made this mistake with Kraft Heinz -- paying up for brand power that turned out to be less durable than assumed. He also made the opposite mistake by passing on companies he admired but thought too expensive, only to watch them compound beyond his wildest expectations. The trick is knowing which category HOYA falls into.

HOYA's competitive position in EUV mask blanks is among the strongest I have encountered in any industry, anywhere in the world. This is not a "market leader" in the typical sense -- it is a gatekeeper. Every advanced semiconductor chip produced by TSMC, Samsung, or Intel passes through a mask made from a HOYA blank. The company operates at a chokepoint in the global technology supply chain that is virtually impossible to replicate. It took decades of co-development with ASML, billions in accumulated process knowledge, and an irreproducible institutional relationship with every major foundry to get here. You cannot buy your way into this position with capital alone -- you need time, trust, and atomic-level precision.

So the real question becomes: what multiple does a chokepoint monopoly in the most important industry of the 21st century deserve? And is 45x trailing earnings that multiple?

2. Hidden Assumptions

When I buy HOYA at JPY 27,545, I am implicitly making several assumptions:

Assumption 1: EUV demand grows at 12%+ for a decade. The shift to 3nm, 2nm, and below requires more EUV layers per wafer -- from ~12 layers at 5nm to potentially 20+ layers at 2nm and beyond. Each layer needs a mask. Each mask needs a blank. This is a structural multiplier, but it assumes foundries continue to pursue Moore's Law economics and that the cost structure of EUV remains viable for chipmakers.

Assumption 2: No alternative lithography emerges. Directed self-assembly, nanoimprint lithography, and electron-beam direct-write have all been explored as EUV alternatives. None are currently competitive at production scale, but a breakthrough would be catastrophic for HOYA's mask blank business. I give this low probability (<5% in the next decade) but cannot dismiss it entirely.

Assumption 3: The yen stays weak or weakens further. HOYA's reported financials have been significantly flattered by yen depreciation. An 80% overseas revenue base means a 20% yen appreciation would directly reduce translated earnings by roughly 16%. The yen at 150/USD is historically weak -- reversion is more likely than continuation.

Assumption 4: 45x P/E is sustainable. Japanese premium-quality stocks have historically traded at elevated multiples, but 45x is at the upper bound. If global rate normalization continues, the discount rate applied to future cash flows rises and the justified multiple contracts. A move from 45x to 35x -- entirely plausible -- represents a 22% price decline with zero change in business quality.

The market's pricing assumes all four of these hold simultaneously. I want at least two to be wrong and still make money. At JPY 27,545, I am not confident that condition is met.

3. The Contrarian View

The contrarian case for buying HOYA now goes something like this: "You are anchoring on trailing multiples and ignoring the structural growth story. EUV mask blanks are in a secular growth inflection. High-NA EUV will double the addressable market. HOYA's earnings three years from now will be 50-70% higher than today, making the forward multiple much more reasonable."

This is a legitimate argument. If HOYA can grow earnings at 15% annualized for three years (which semiconductor expansion could support), the stock at JPY 27,545 would trade at roughly 26x 2029 earnings. That would be reasonable.

The counter-contrarian response: markets are efficient enough that obvious secular growth stories get priced in quickly. HOYA has rallied 57% in 12 months precisely because institutional investors have done this math. The semiconductor AI narrative is consensus. What is not priced in is the next cyclical downturn -- the one that comes after the build-out peaks and digestion begins. In semiconductors, the downturn always comes. The question is when, not if.

4. The Simplest Thesis

If I had to explain HOYA to a ten-year-old:

"HOYA makes the special glass plates that are used to create the tiny circuits inside every computer chip and smartphone. Nobody else can make these plates as good as HOYA can, so every big chip company has to buy from them. HOYA also makes eyeglass lenses and medical instruments that doctors use. The company has no debt and makes a lot of money. But right now, everyone knows how good HOYA is, so the stock price is very high. We want to wait until there is a sale."

That is the thesis. The elegance of a business this simple -- sell irreplaceable components at high margins to customers who have no alternative -- is that it requires almost no management heroics to produce excellent results. The risk is entirely in the price paid.

5. Why This Opportunity Exists

The opportunity does not exist today at JPY 27,545. The opportunity will exist when one of the following occurs:

Semiconductor cyclical downturn (most likely). Every 3-5 years, chip demand overshoots supply, followed by inventory correction and capex reduction. HOYA's IT segment profits can decline 20-25% in a downturn. The market, being reflexive, will price in further deterioration at the bottom. This is when you buy.
Yen normalization. The Bank of Japan has begun normalizing monetary policy. If 10-year JGB yields move from 1.4% toward 2%, the yen will strengthen and HOYA's translated earnings will decline. Paradoxically, the underlying business may be stronger at that point, but the reported numbers will look worse. This creates a perception gap.
Broad market de-rating. Japan's TOPIX has rallied significantly. If global risk appetite declines, Japanese equities will correct. HOYA, trading at a premium, will likely correct more than the index.

The stock hit JPY 14,441 just ten months ago. The business was essentially the same then as it is now. Mr. Market offered you a chance to buy this chokepoint monopoly at 24x forward earnings. He may offer it again.

6. What Would Change My Mind

I would buy HOYA at the current price if any of the following were true:

FCF growth accelerated to 15%+ sustainably. If High-NA EUV demand exceeded all projections and life care growth re-accelerated, the stock could genuinely be cheap at 45x today's earnings.
The company made a transformative acquisition in an adjacent monopoly (advanced packaging substrates, for example) that added a second chokepoint business at a reasonable price.
AGC permanently exited the mask blank market, giving HOYA 90%+ share and even greater pricing power.

Conversely, I would permanently avoid HOYA if:

A viable alternative to EUV lithography reached production scale within 5 years.
AGC achieved defect parity on EUV blanks and began winning meaningful share.
Management abandoned capital discipline by pursuing large, dilutive acquisitions outside their circle of competence.

7. The Soul of This Business

HOYA's soul is precision. Founded in 1941 as an optical glass manufacturer, the company has spent 85 years refining its mastery of light, glass, and surfaces at the atomic level. There is something philosophically satisfying about a company whose core competence is making things clearer -- whether that is an eyeglass lens that corrects your vision, a medical endoscope that lets a surgeon see inside the human body, or a mask blank that transfers a circuit pattern with nanometre accuracy onto a silicon wafer.

In a world of software businesses with zero marginal cost and low barriers to entry, HOYA represents the opposite paradigm: a physical-world manufacturer where the barriers to entry are decades of accumulated knowledge, irreproducible relationships, and the laws of physics. You cannot fork HOYA's source code. You cannot pivot into mask blanks from a WeWork. The moat is not a network effect that can evaporate overnight -- it is encoded in the molecular structure of ultra-flat glass substrates with sub-picometre roughness.

The Japanese manufacturing ethos of monozukuri -- the art of making things with obsessive attention to detail -- finds its purest expression in companies like HOYA. This cultural moat, invisible on any balance sheet, may be the most durable advantage of all.

But monozukuri has a price, and at JPY 27,545, the price is too high. The patient investor recognizes that time is the friend of the wonderful business. There will come a day when the market offers HOYA at a price that reflects its quality but not its permanence. That will be the day to act.

Until then, we wait.

"The stock market is designed to transfer money from the Active to the Patient." -- Warren Buffett

Executive Summary

HOYA Corporation is a world-class business masquerading as a diversified optics firm. It commands irreplaceable monopoly positions -- 75%+ of EUV mask blanks for advanced semiconductor lithography and 100% of HDD glass substrates -- while simultaneously operating the world's second-largest eyeglass lens business. The company generates 24% ROE with virtually no leverage (net cash of JPY 539B), converts profits into free cash flow at extraordinary rates, and has returned over JPY 100B annually to shareholders through buybacks and dividends. However, at JPY 27,545 per share (45x trailing earnings, 36x EV/EBITDA), the market already prices in exceptional quality and growth. This is a fortress business trading at a price that demands perfection.

Key Metrics at a Glance:

Metric	Value	Assessment
Market Cap	JPY 9,312B ($62B)	Large-cap
P/E (Trailing)	45.2x	Premium
P/E (Forward)	40.3x	Premium
EV/EBITDA	36.4x	Premium
FCF Yield	2.0%	Low
ROE	24.2%	Excellent
ROIC	33.3%	Exceptional
D/E Ratio	0.04x	Fortress balance sheet
Net Cash	JPY 539B	JPY 1,595/share
3-Year Revenue CAGR	9.7%	Solid
Operating Margin	42.7%	World-class

Phase 1: Risk Analysis (Inversion First)

Charlie Munger taught us to invert -- to think about what could go wrong before fantasizing about what could go right. Here are the five most significant risks, ranked by expected impact (probability x severity).

Risk 1: EUV Technology Disruption or Competitive Entry

Probability: 10% | Severity: -40% | Expected Impact: -4.0%

HOYA's crown jewel is its 75%+ share of EUV mask blanks. The moat here is extraordinary -- 5-7 year qualification cycles, $2.5-3.0B greenfield replication cost, ISO Class 1 cleanroom requirements, and deep co-development ties with ASML. However, AGC (Asahi Glass) is the only semi-credible competitor and is investing heavily. If a geopolitical event forced chip foundries to diversify suppliers, or if a breakthrough in maskless lithography emerged, HOYA's most profitable business could face erosion. The saving grace: High-NA EUV blanks (for sub-2nm nodes) are currently HOYA-only, and each new generation resets the qualification clock.

Risk 2: Semiconductor Cyclicality

Probability: 35% | Severity: -20% | Expected Impact: -7.0%

The Information Technology segment (~33% of revenue, ~50% of profit) is tied to semiconductor capital expenditure cycles. In a semiconductor downturn -- which historically occurs every 3-5 years -- mask blank volumes can decline 15-25%. The HDD glass substrate business faces secular decline risk as SSDs capture more data center storage share. However, EUV mask blank growth should structurally offset HDD weakness as leading-edge node adoption accelerates.

Risk 3: Valuation Compression

Probability: 40% | Severity: -25% | Expected Impact: -10.0%

At 45x trailing earnings and 36x EV/EBITDA, HOYA trades at a premium even by quality-compounder standards. If global interest rates remain elevated, if Japan's monetary policy normalizes further, or if growth disappoints even slightly, multiple compression from 45x to 30x earnings would imply a 33% price decline to ~JPY 18,300 -- even with no deterioration in fundamentals. This is the single largest risk at current prices.

Risk 4: Yen Appreciation

Probability: 30% | Severity: -15% | Expected Impact: -4.5%

HOYA reports in JPY but earns approximately 80% of revenue overseas. The weak yen has been a significant tailwind, inflating reported revenues and margins. If the yen strengthens from 150 to 120 against the USD (a 20% move), translated earnings would decline materially. With a beta of only 0.56, the stock may not fully reflect currency risk.

Risk 5: Life Care Competitive Pressure

Probability: 25% | Severity: -15% | Expected Impact: -3.75%

The Life Care segment (67% of revenue) faces competition from Johnson & Johnson, Bausch + Lomb, and EssilorLuxottica. While HOYA is #2 globally in eyeglass lenses, pricing pressure in medical devices and potential disruption in contact lenses could squeeze margins. Regulatory delays (FDA/EMA) on medical devices add further uncertainty. The 2024 ransomware attack (Hunters International, $10M ransom demand) exposed operational vulnerability.

Risk Summary Table

Risk	Probability	Severity	Expected Impact
EUV Technology Disruption	10%	-40%	-4.0%
Semiconductor Cyclicality	35%	-20%	-7.0%
Valuation Compression	40%	-25%	-10.0%
Yen Appreciation	30%	-15%	-4.5%
Life Care Competition	25%	-15%	-3.75%
Total Expected Downside			-29.3%

Tail Risk: A simultaneous semiconductor downturn + yen appreciation + multiple compression could create a 40-50% drawdown scenario (to JPY 14,000-16,500). This is not improbable -- it essentially describes what happened in mid-2024 when the stock touched JPY 14,441.

Phase 2: Financial Analysis

A. ROE Decomposition (DuPont Analysis)

Component	Value	Assessment
Net Profit Margin	27.4%	Exceptional
Asset Turnover	0.74x	Moderate (asset-light)
Equity Multiplier	1.27x	Conservative (low leverage)
ROE	24.2%	Excellent

HOYA's ROE is driven almost entirely by profitability, not leverage. This is the hallmark of a truly great business -- it does not need to borrow money to generate superior returns. The 24% ROE on a 1.27x equity multiplier implies the underlying business economics are exceptional. By contrast, a company generating 24% ROE with 3x leverage would be far more fragile.

ROIC of 33.3% confirms that HOYA earns outstanding returns on every dollar of capital deployed. This is the single most important number for a long-term investor -- it represents the rate at which the business compounds intrinsic value over time.

B. Free Cash Flow Analysis

Year	OCF (JPY B)	CapEx (JPY B)	FCF (JPY B)	FCF Margin
2022	190.1	28.9	161.2	24.0%
2023	201.8	33.5	168.4	22.9%
2024	222.8	41.1	181.7	22.9%
2025	235.1	47.9	187.2	21.1%

Key observations:

CapEx discipline: CapEx has grown from JPY 28.9B to JPY 47.9B (66% increase), but remains well below depreciation, indicating HOYA can maintain its business with modest reinvestment. This is a sign of a high-quality, asset-light business model.
FCF conversion: FCF/Net Income averages ~75%, which is solid. The gap is largely driven by working capital timing and rising capex for EUV capacity expansion.
FCF per share: JPY 554. At the current price of JPY 27,545, this implies a 2.0% FCF yield. For context, Japanese 10-year government bonds yield approximately 1.4%. The premium is thin for equities.
Capital allocation: In FY2025, HOYA paid JPY 38.4B in dividends (20.5% of FCF) and spent approximately JPY 100B on share buybacks. Total shareholder returns of ~JPY 138B represent 74% of FCF -- a clear commitment to returning capital.

C. Balance Sheet Fortress

Metric	Value
Cash & Equivalents	JPY 580.6B
Total Debt	JPY 41.4B
Net Cash	JPY 539.2B
Net Cash/Share	JPY 1,595
Current Ratio	4.96x
Quick Ratio	4.05x
D/E Ratio	0.04x

HOYA's balance sheet is a fortress. Net cash of JPY 539B represents 5.8% of market cap -- essentially, you're buying the operating business for JPY 8,773B enterprise value. The near-zero leverage means HOYA can weather any cyclical downturn, pursue opportunistic M&A, or accelerate buybacks during market dislocations. This is exactly the kind of balance sheet Buffett admires.

D. DCF Valuation

Assumptions:

Scenario	FCF Growth (Yr 1-5)	Transition Growth (Yr 6-10)	Terminal Growth	Discount Rate
Conservative	8%	5.5%	3.0%	9.0%
Base	10%	6.75%	3.5%	8.5%
Optimistic	12%	8.0%	4.0%	8.0%

Starting FCF/Share: JPY 554

Scenario	DCF Value	+ Net Cash	Intrinsic Value	vs Current
Conservative	JPY 12,804	JPY 1,595	JPY 14,399	+91% premium
Base	JPY 17,028	JPY 1,595	JPY 18,623	+48% premium
Optimistic	JPY 23,680	JPY 1,595	JPY 25,275	+9% premium

Interpretation: Even under optimistic assumptions (12% FCF growth for 5 years, 4% terminal growth, 8% discount rate), HOYA's intrinsic value barely reaches the current price. The market is pricing in sustained excellence and above-optimistic growth for an extended period.

To justify the current price of JPY 27,545, you would need approximately 14% FCF growth for 10 years with a 4% terminal growth rate at an 8% discount rate. This is possible given HOYA's competitive position, but it leaves essentially zero margin of safety.

E. Historical Valuation Context

Metric	Current	5-Year Average*	Assessment
P/E	45.2x	~35-40x	Above average
P/B	9.1x	~6-7x	Above average
EV/EBITDA	36.4x	~25-30x	Above average
FCF Yield	2.0%	~2.5-3.0%	Below average

*Estimated from historical price and earnings data.

HOYA's current multiples are at or near the high end of its historical range. The stock has rallied 57.5% in the past 12 months and 130.8% over 5 years, driven by EUV mask blank enthusiasm and yen weakness.

Phase 3: Moat Analysis

Moat Rating: WIDE

HOYA possesses one of the most defensible competitive positions in global manufacturing. The moat is wide, deep, and -- most critically -- widening.

Source 1: Monopoly-Like Market Position in EUV Mask Blanks

Moat Type: Switching Costs + Technological Lead + Regulatory Lock-In

HOYA commands 75%+ of the global EUV mask blank market. This is not a typical market share advantage -- it functions as a de facto monopoly for several structural reasons:

Co-development with ASML: Each generation of EUV mask blanks must be co-developed and co-qualified with ASML's scanner roadmap. HOYA's blanks are designed around specific optical constants and defect profiles that foundries (TSMC, Samsung, Intel) have built their mask shops around. Switching would require 5-7 years of requalification.
Defect tolerance at the atomic level: Surface defects exceeding tens of nanometres are disqualifying. Phase defects must remain below 0.1/cm2 at 13.5nm actinic wavelengths. HOYA achieves this at volume production scale; AGC does not yet.
High-NA EUV exclusivity: As of 2025, HOYA is understood to be the only vendor with validated blank products for High-NA EUV systems (0.55 NA), critical for logic nodes below 2nm. This is the next frontier, and HOYA has already won it.
Capital barriers: Greenfield replication of a HOYA-class facility would require $2.5-3.0B in investment, ISO Class 1+ cleanrooms, and custom proprietary deposition equipment.

Average selling prices of $8,000-$15,000+ per blank with EBIT margins exceeding 30% make this one of the most profitable niches in the entire semiconductor supply chain.

Source 2: Absolute Monopoly in HDD Glass Substrates

Moat Type: Scale + Process Expertise

HOYA holds 100% of the HDD glass substrate market. While this business faces secular headwinds from SSD adoption, the transition to energy-assisted magnetic recording (HAMR/MAMR) in data center drives specifically requires glass substrates (not aluminum), which could extend the addressable market. This is a niche monopoly generating high-margin revenue.

Source 3: Scale and Specialization in Life Care

Moat Type: Brand + Scale + Distribution

HOYA is the #2 global eyeglass lens manufacturer (behind EssilorLuxottica) with approximately 20% market share. The eyeglass lens business benefits from:

Aging global demographics (presbyopia increases after age 40)
Rising screen time driving myopia in younger populations
Premium lens technology (progressive, photochromic, coatings)
Global distribution through Eyecity retail chain and third-party opticians

The medical endoscope business (competing with Olympus) and intraocular lens business add healthcare diversification with growing demand from aging populations worldwide.

Source 4: Capital-Light Business Model

Moat Type: Operational Excellence

HOYA's capital expenditures consistently run below depreciation, a rare characteristic for a manufacturer. The company maintains ~80% factory utilization through conservative 2-3 year capex planning. Tangible fixed assets have barely grown while revenue has expanded significantly. This asset-light model means HOYA can grow earnings without consuming proportional capital -- the hallmark of a business Buffett would love.

Moat Durability Assessment

Factor	Assessment	Trend
EUV Mask Blanks	Near-monopoly, 5-7yr requalification cycles	Widening (High-NA EUV)
HDD Glass Substrates	100% share but secular headwinds	Stable/Narrowing
Eyeglass Lenses	#2 globally, scale advantage	Stable
Medical Devices	Competitive but growing	Stable
Overall	Wide moat, durable 15+ years	Widening

Phase 4: Decision Synthesis

Buffett Checklist

Criterion	HOYA	Pass?
Understand the business	Optical technology + healthcare	Yes
Durable competitive advantage	Wide moat, monopoly positions	Yes
Excellent management	Shareholder-oriented, buybacks	Yes
ROE > 15% consistently	20%+ for 20 years	Yes
Low debt	Net cash JPY 539B	Yes
High operating margins	42.7%	Yes
Free cash flow generation	JPY 187B annually	Yes
Reasonable price	45x P/E, 2% FCF yield	No

Seven of eight criteria pass. The lone failure -- valuation -- is the critical one.

Intrinsic Value Summary

Method	Value Range (JPY)
DCF (Conservative)	14,399
DCF (Base)	18,623
DCF (Optimistic)	25,275
Current Price	27,545

Entry Prices

Level	Price (JPY)	P/E Implied	Margin of Safety
Strong Buy	14,400	~24x	25% below conservative fair value
Accumulate	18,600	~31x	15% below base fair value
Fair Value (Base)	18,600	~31x	0%
Sell/Trim	27,800	~46x	10% above optimistic fair value

Verdict: WAIT

Recommendation: WAIT -- Admire the business, but respect the price.

HOYA Corporation is a genuinely exceptional business. Its combination of monopoly market positions, world-class margins, fortress balance sheet, and disciplined capital allocation makes it one of the highest-quality companies listed in Asia. The EUV mask blanks business is a mission-critical chokepoint in global semiconductor manufacturing with no practical alternative.

However, quality has a price, and at JPY 27,545, the market is paying for perfection with no margin of safety. The stock trades near its all-time high, at 45x trailing earnings and a 2% FCF yield. Even optimistic DCF assumptions barely justify the current price. A 30% decline -- to the JPY 18,000-19,000 range -- would bring the stock into "fair value" territory where patient investors could build a position with confidence.

The ideal entry scenario: A semiconductor cyclical downturn, yen strengthening, or broad market correction that brings HOYA below JPY 19,000 (30x earnings). The stock touched JPY 14,441 just ten months ago -- these opportunities come more often than the market implies.

Action Plan:

Add HOYA to watchlist at JPY 18,600 (Accumulate) and JPY 14,400 (Strong Buy)
Monitor semiconductor capex cycles for timing
Watch for yen/USD reversal as potential catalyst for entry
Review after next earnings (expect June 2026)

Appendix: Data Sources

HOYA Corporation financial statements (FY2022-FY2025)
HOYA Corporation company-info.json (yfinance)
HOYA REPORT 2024 (hoya.com/ir/2024)
Hennessy Funds: HOYA Spotlight
Mask Blanks & Substrate Sovereigns
EODHD historical price data